Carbidopa, Levodopa and Entacapone 31.25 mg/1 (Carbidopa, Levodopa and Entacapone TABLET, FILM COATED) 31.25 mg/1

Carbidopa, Levodopa and Entacapone 31.25 mg/1 tablets are a combination medication used to manage symptoms of Parkinson's disease. This oral treatment helps improve muscle control and reduce tremors.

Strength

31.25 mg/1

Pack Size

10 BLISTER PACK in 1 CARTON (33342-494-12) / 10 TABLET, FILM COATED in 1 BLISTER PACK

Manufacturer / TM Owner

Macleods Pharmaceuticals Limited

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Carbidopa, Levodopa and Entacapone 31.25 mg/1 tablets are primarily used to treat Parkinson's disease. The medication works by increasing dopamine levels in the brain, which helps to alleviate symptoms such as stiffness, tremors, and muscle spasms. This combination therapy is often prescribed when other treatments are not effective. People often ask, 'What is Carbidopa, Levodopa and Entacapone used for?' and the answer is that it is used to manage the symptoms of Parkinson's disease.

Side Effects

Common effects of Carbidopa, Levodopa and Entacapone 31.25 mg/1 tablets may include nausea, dizziness, and headache. Some users may experience involuntary movements or changes in mood. These effects can vary from person to person and may subside as the body adjusts to the medication.

Precautions & Warnings

It is important to handle Carbidopa, Levodopa and Entacapone 31.25 mg/1 tablets with care. Store them in a cool, dry place away from direct sunlight. Always follow the instructions provided by your healthcare professional. Do not share this medication with others, even if they have similar symptoms.

Avoid Interactions

Carbidopa, Levodopa and Entacapone 31.25 mg/1 tablets may interact with other medications, including antidepressants, blood pressure drugs, and certain pain relievers. Always inform your healthcare provider about all the medications you are taking to avoid potential interactions. Alcohol should be avoided while using this medication.

Frequently Asked Questions

Carbidopa, Levodopa and Entacapone 31.25 mg/1 tablets are used to manage symptoms of Parkinson's disease, such as tremors and muscle stiffness.

Store Carbidopa, Levodopa and Entacapone 31.25 mg/1 tablets in a cool, dry place away from direct sunlight and out of reach of children.

Common side effects may include nausea, dizziness, headache, and involuntary movements. These effects can vary from person to person.

It is generally advised to avoid alcohol while taking Carbidopa, Levodopa and Entacapone 31.25 mg/1 tablets to prevent potential interactions.

If you miss a dose, take it as soon as you remember. However, if it is almost time for your next dose, skip the missed dose and continue with your regular schedule.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.